• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Certara, Inc. - Common Stock (NQ: CERT )

    10.69 -0.16 (-1.47%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 882,162
    Open 10.80
    Bid (Size) 10.10 (9)
    Ask (Size) 10.94 (2)
    Prev. Close 10.85
    Today's Range 10.51 - 10.95
    52wk Range 9.410 - 19.87
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Certara Showcases 2024 Research Wins With Over 100 Papers Published
    The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list 
    From Certara
    Via GlobeNewswire
    Forecasting The Future: 4 Analyst Projections For Certara
    Via Benzinga

    Performance

    YTD
    -38.39%
    -38.39%
    1 Month
    -5.15%
    -5.15%
    3 Month
    -9.02%
    -9.02%
    6 Month
    -22.82%
    -22.82%
    1 Year
    -40.28%
    -40.28%

    More News

    Read More
    Certara Reports Third Quarter 2024 Financial Results
    From Certara
    Via GlobeNewswire
    Certara to Participate in the Stephens Annual Investment Conference
    From Certara
    Via GlobeNewswire
    Beyond The Numbers: 4 Analysts Discuss Certara Stock
    Via Benzinga
    Beyond The Numbers: 4 Analysts Discuss Certara Stock
    Via Benzinga
    Certara Appoints John Reynders as New Independent Board Member
    From Certara
    Via GlobeNewswire
    MaxCyte Appoints Cynthia Collins to its Board of Directors
    From MaxCyte, Inc
    Via GlobeNewswire
    Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
    From Certara
    Via GlobeNewswire
    Certara Completes Acquisition of Chemaxon
    From Certara
    Via GlobeNewswire
    IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Certara’s Simcyp Consortium Celebrates 25th Anniversary
    From Certara
    Via GlobeNewswire
    Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
    From Certara
    Via GlobeNewswire
    Certara to Participate in Upcoming Investor Conferences
    From Certara
    Via GlobeNewswire
    Certara Launches Phoenix™ Version 8.5 Drug Development Software
    From Certara
    Via GlobeNewswire
    CERT Stock Earnings: Certara Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Certara Reports Second Quarter 2024 Financial Results
    From Certara
    Via GlobeNewswire
    Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
    From Certara
    Via GlobeNewswire
    Simulations Plus Stock Drops 15% Despite EPS Beat
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
    From Certara
    Via GlobeNewswire
    Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
    From Certara
    Via GlobeNewswire
    Certara to Participate in the Jefferies Global Healthcare Conference
    From Certara
    Via GlobeNewswire
    Certara Appoints New Chief Human Resources Officer & General Counsel
    From Certara
    Via GlobeNewswire
    CERT Stock Earnings: Certara Meets EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.